Steven M. Goldman, Director at Dova Pharmaceuticals, Inc. (DOVA), bought 40,338 shares at $21.86 ($897K) on 2017-08-15, disclosed to the SEC on 2017-08-17.
Open-market purchase of $897k DOVA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.86 | 9,158 | $200K | 22.3% |
| 2 | $21.86 | 9,158 | $200K | 22.3% |
| 3 | $22.54 | 11,011 | $248K | 27.7% |
| 4 | $22.54 | 11,011 | $248K | 27.7% |
| Total | $22.23 avg | 40,338 | $897K | 100% |
| Filing → |
| DOVA | BUY | 2017-08-17 | $98K | — | Filing → |
| CNOB | BUY | 2014-02-06 | $111K | — | Filing → |
| CNOB | BUY | 2014-02-04 | $46K | — | Filing → |